Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential

Novel immunotargets in multiple myeloma: biological relevance and therapeutic potential

Abstract Multiple myeloma is a hematologic malignancy characterized by complex genetic and microenvironmental factors that drive disease progression and resistance to treatment. Despite advancements in therapies targeting established antigens, such as BCMA, CD38, SLAMF7, and GPRC5D, specific challen...

Full description

Saved in:
Bibliographic Details
Main Authors: Jana Kotulová, Klára Baďurová, Zuzana Chyra, Sabina Ševčíková, Nikola Garbová, Tomáš Jelínek, Roman Hájek, Matouš Hrdinka
Format: Article
Language:English
Published: BMC 2025-07-01
Series:Biomarker Research
Subjects:
Multiple myeloma
Aberrant plasma cells
Hematooncology
Immunotarget
Immunotherapy
Surface proteome
Online Access:https://doi.org/10.1186/s40364-025-00799-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40364-025-00799-7

Similar Items